C
IRON icon

Covestor’s Disc Medicine IRON Stock Holding History

Covestor’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
2
– – ﹤0.01% 2515
2025
Q4 		$0 Hold
2
– – ﹤0.01% 2490
2025
Q3 		$0 Hold
2
– – ﹤0.01% 2507
2025
Q2 		$0 Hold
2
– – ﹤0.01% 2460
2025
Q1 		$0 Hold
2
– – ﹤0.01% 2466
2024
Q4 		$0 Hold
2
– – ﹤0.01% 2475
2024
Q3 		$0 Hold
2
– – ﹤0.01% 2456
2024
Q2 		$0 Sell
2
-8
-80% -$272 ﹤0.01% 2475
2024
Q1 		$1K Buy
10
+8
+400% +$519 ﹤0.01% 2004
2023
Q4 		$0 Hold
2
– – ﹤0.01% 2398
2023
Q3 		$0 Buy
+2
New +$100 ﹤0.01% 2386

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Covestor's IRON Position: Q1 2026 in Review

Covestor held its Disc Medicine (IRON) position steady in Q1 2026 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2515.

Covestor first reported a position in IRON in Q3 2023 and has held it in 11 quarters since. The position peaked at $1K in Q1 2024. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Covestor held 2 shares of Disc Medicine worth $0 as of Q1 2026.
  • Covestor left its Disc Medicine share count unchanged in Q1 2026.
  • Disc Medicine made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2515 holding.
  • Covestor first reported a position in Disc Medicine in Q3 2023 and has held it in 11 quarters since.
  • Covestor's Disc Medicine position peaked at $1K in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.